首页> 美国卫生研究院文献>Journal of Anatomy and Physiology >Glucocorticoids induce glutamine synthetase in folliculostellate cells of rat pituitary glands in vivo and in vitro
【2h】

Glucocorticoids induce glutamine synthetase in folliculostellate cells of rat pituitary glands in vivo and in vitro

机译:糖皮质激素在体内和体外诱导大鼠垂体滤泡卫星细胞中的谷氨酰胺合成酶

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Glutamine synthetase (GS) is a glucocorticoid-inducible enzyme that has a key role for glutamate metabolism in the central and peripheral nervous system. In this study GS activity was measured and the amount of immunoreactive GS (ir-GS) cells in the rat anterior pituitary gland was quantified as a function of age. In addition, the effects of GS inhibitors, glucocorticoid administration, and adrenalectomy on GS activity were examined. Some of the ir-GS cells were also immunoreactive for S100 protein (ir-S100) which is a known marker for folliculostellate cells (FS) in the anterior pituitary. FS cells expressing GS were first detected in 3-d-old rats, and this cell population, expressed as the immunostained cell area divided by a standard unit area, increased as a function of age. The percentages of FS cells also expressing GS were 0.2, 6.4, 25 and 74% at 3 d, 30 d, 60 d and 2 y of age, respectively. GS enzyme activity also increased in parallel with the increase of ir-GS cell population maturation. The subcutaneous injection of methionine sulphoximine, a GS and γ-glutamylcysteine synthetase inhibitor, reduced pituitary GS activity by 83%, but increased the population of ir-GS cells 3.5-fold in 30-d-old rats. Buthionine sulphoximine, a specific inhibitor of γ-glutamylcysteine synthetase, had little effect on GS activity or the ir-GS cell population. Neither methionine sulphoximine nor buthionine sulphoximine changed the population of ir-S100 protein cells (FS cells). Dexamethasone and hydrocortisone increased the population of ir-GS cells by 3.1 and 4.2-fold, respectively, within 12 h after administration. A significant increase of GS activity due to the injection of glucocorticoids was observed in the anterior pituitary, but not in the brain, retina or liver of immature rats. Adrenalectomy did not cause decrease of pituitary GS activity, and dexamethasone administration increased GS activity in both adrenalectomised and intact rats. In the monolayer culture of anterior pituitary cells, glucocorticoids increased GS activity by ×1.5, and methionine sulphoximine reduced the activity by over 94%. These results demonstrate that GS in folliculostellate cells is a glucocorticoid-inducible enzyme in vivo and in vitro, and that the age-dependent increase of GS activity is independent of endogenous adrenal glucocorticoids.
机译:谷氨酰胺合成酶(GS)是一种糖皮质激素诱导型酶,对于中枢神经系统和周围神经系统的谷氨酸代谢具有关键作用。在这项研究中,测量了GS活性,并根据年龄对大鼠垂体前腺中免疫反应性GS(ir-GS)细胞的数量进行了定量。此外,检查了GS抑制剂,糖皮质激素的给药和肾上腺切除术对GS活性的影响。一些ir-GS细胞也对S100蛋白(ir-S100)具有免疫反应性,S100蛋白是垂体前叶卵泡细胞(FS)的已知标记。首先在3日龄大鼠中检测到表达GS的FS细胞,并且该细胞群(以免疫染色的细胞面积除以标准单位面积表示)随年龄增长而增加。在3岁,30岁,60岁和2岁时也表达GS的FS细胞的百分比分别为0.2%,6.4%,25%和74%。 GS酶的活性也随着ir-GS细胞群体成熟的增加而增加。皮下注射甲硫氨酸亚砜亚胺,一种GS和γ-谷氨酰半胱氨酸合成酶抑制剂,可使垂体GS活性降低83%,但使30天大的大鼠的ir-GS细胞数量增加了3.5倍。丁硫氨酸亚砜亚胺,一种γ-谷氨酰半胱氨酸合成酶的特异性抑制剂,对GS活性或ir-GS细胞群几乎没有影响。甲硫氨酸亚砜亚胺和丁硫氨酸亚砜亚胺都不能改变ir-S100蛋白细胞(FS细胞)的数量。给药后12小时内,地塞米松和氢化可的松将ir-GS细胞的数量分别增加了3.1倍和4.2倍。在未成熟大鼠的垂体前叶中观察到由于注射糖皮质激素引起的GS活性显着增加,但未在大脑,视网膜或肝脏中观察到。肾上腺切除术并不会导致垂体GS活性降低,地塞米松的给药在肾上腺切除和完整大鼠中都增加了GS活性。在垂体前叶细胞的单层培养中,糖皮质激素将GS活性提高了1.5倍,而蛋氨酸亚砜肟的活性降低了94%以上。这些结果表明,卵泡状细胞中的GS在体内和体外是糖皮质激素诱导的酶,并且GS活性的年龄依赖性增加与内源性肾上腺糖皮质激素无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号